{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T10:40:05Z","timestamp":1747564805359,"version":"3.40.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,18]]},"DOI":"10.7759\/cureus.84321","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T09:58:40Z","timestamp":1747562320000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Asem","family":"Aldebei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara S","family":"Hammouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah A","family":"Abdallat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees","family":"Hjazeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alsharif M","family":"Muhanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Arnous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Alshwayyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alkotob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-00240-7","article-title":"\"'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:\" a qualitative interview study to understand the psychosocial burden of alopecia areata","volume":"4","author":"Aldhouse NV","year":"2020","unstructured":"Aldhouse NV, Kitchen H, Knight S, et al.. \"'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:\" a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020, 4:76. 10.1186\/s41687-020-00240-7","journal-title":"J Patient Rep Outcomes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam N","year":"2015","unstructured":"Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015, 14:81-9. 10.1016\/j.autrev.2014.10.014","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu SY","year":"2011","unstructured":"Chu SY, Chen YJ, Tseng WC, et al.. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011, 65:949-56. 10.1016\/j.jaad.2010.08.032","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1963.01590210048007","article-title":"Alopecia areata. An evaluation of 736 patients","volume":"88","author":"Muller SA","year":"1963","unstructured":"Muller SA, Winkelmann RK. Alopecia areata. An evaluation of 736 patients. Arch Dermatol. 1963, 88:290-7. 10.1001\/archderm.1963.01590210048007","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S266409","article-title":"Alopecia areata: an autoimmune disease of multiple players","volume":"10","author":"Suchonwanit P","year":"2021","unstructured":"Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia areata: an autoimmune disease of multiple players. Immunotargets Ther. 2021, 10:299-312. 10.2147\/ITT.S266409","journal-title":"Immunotargets Ther"},{"key":"ref6","article-title":"HLA class II antigen associations help to define two types of alopecia areata","volume":"33","author":"Colombe BW","year":"1995","unstructured":"Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol. 1995, 33:757-64.","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2015.28","article-title":"Clinical Efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"17","author":"Chiang KS","year":"2015","unstructured":"Chiang KS, Mesinkovska NA, Piliang MP, Bergfeld WF. Clinical Efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients. J Investig Dermatol Symp Proc. 2015, 17:50-5. 10.1038\/jidsymp.2015.28","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King BA","year":"2023","unstructured":"King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023, 89:S29-32. 10.1016\/j.jaad.2023.05.049","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing M","year":"2022","unstructured":"Lensing M, Jabbari A. An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata. Front Immunol. 2022, 13:955035. 10.3389\/fimmu.2022.955035","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000531219","article-title":"Racial and ethnic diversity in Janus kinase inhibitor alopecia areata clinical trials: a systematic review","volume":"9","author":"Ezemma O","year":"2023","unstructured":"Ezemma O, Devjani S, Jothishankar B, Kelley KJ, Senna M. Racial and ethnic diversity in Janus kinase inhibitor alopecia areata clinical trials: a systematic review. Skin Appendage Disord. 2023, 9:351-4. 10.1159\/000531219","journal-title":"Skin Appendage Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231168839","article-title":"Alopecia areata: an updated review for 2023","volume":"27","author":"Sibbald C","year":"2023","unstructured":"Sibbald C. Alopecia areata: an updated review for 2023. J Cutan Med Surg. 2023, 27:241-59. 10.1177\/12034754231168839","journal-title":"J Cutan Med Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae058","article-title":"Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study","volume":"191","author":"Jeon JJ","year":"2024","unstructured":"Jeon JJ, Jung SW, Kim YH, et al.. Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study. Br J Dermatol. 2024, 191:325-35. 10.1093\/bjd\/ljae058","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.17352\/jvi.000054","article-title":"Alopecia areata","volume":"9","author":"Chen C","year":"2023","unstructured":"Chen C. Alopecia areata. J Vaccines Immunol. 2023, 9:1-5. 10.17352\/jvi.000054","journal-title":"J Vaccines Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19768","article-title":"European expert consensus statement on the systemic treatment of alopecia areata","volume":"38","author":"Rudnicka L","year":"2024","unstructured":"Rudnicka L, Arenbergerova M, Grimalt R, et al.. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024, 38:687-94. 10.1111\/jdv.19768","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.04.077","article-title":"Treatment of pediatric alopecia areata: a systematic review","volume":"86","author":"Barton VR","year":"2022","unstructured":"Barton VR, Toussi A, Awasthi S, Kiuru M. Treatment of pediatric alopecia areata: a systematic review. J Am Acad Dermatol. 2022, 86:1318-34. 10.1016\/j.jaad.2021.04.077","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.33140\/mcr.09.04.05","article-title":"Past, present and future treatment of alopecia areata","volume":"9","author":"Abadie MA","year":"2024","unstructured":"Abadie MA, Tukmatchy H, Mohammed A, Al-Saaty A. Past, present and future treatment of alopecia areata. Med Clin Res. 2024, 9:1-6. 10.33140\/mcr.09.04.05","journal-title":"Med Clin Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19797","article-title":"Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta-analysis","volume":"38","author":"Husein-ElAhmed H","year":"2024","unstructured":"Husein-ElAhmed H, Husein-ElAhmed S. Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta-analysis. J Eur Acad Dermatol Venereol. 2024, 38:835-43. 10.1111\/jdv.19797","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00764-w","article-title":"Efficacy and safety of baricitinib in patients with severe alopecia areata over 52 weeks of continuous therapy in two phase III trials (BRAVE-AA1 and BRAVE-AA2)","volume":"24","author":"Kwon O","year":"2023","unstructured":"Kwon O, Senna MM, Sinclair R, et al.. Efficacy and safety of baricitinib in patients with severe alopecia areata over 52 weeks of continuous therapy in two phase III trials (BRAVE-AA1 and BRAVE-AA2). Am J Clin Dermatol. 2023, 24:443-51. 10.1007\/s40257-023-00764-w","journal-title":"Am J Clin Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16666","article-title":"Comparative efficacy and safety of baricitinib against traditional therapies in severe alopecia areata: a\u00a0retrospective cohort study","volume":"24","author":"Stefanis AJ","year":"2025","unstructured":"Stefanis AJ, Dolezal T, Gkalpakiotis S, Arenberger P. Comparative efficacy and safety of baricitinib against traditional therapies in severe alopecia areata: a\u00a0retrospective cohort study. J Cosmet Dermatol. 2025, 24:e16666. 10.1111\/jocd.16666","journal-title":"J Cosmet Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King B","year":"2022","unstructured":"King B, Ohyama M, Kwon O, et al.. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med. 2022, 386:1687-99. 10.1056\/NEJMoa2110343","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-04035-y","article-title":"Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure","volume":"317","author":"Ehsani A","year":"2025","unstructured":"Ehsani A, Razavi Z, Rahimnia A, Ehsani A, Saberi F, Aryanian Z, Babaie H. Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure. Arch Dermatol Res. 2025, 317:491. 10.1007\/s00403-025-04035-y","journal-title":"Arch Dermatol Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.050","article-title":"Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: phase 2 results from a randomized controlled study","volume":"85","author":"King B","year":"2021","unstructured":"King B, Ko J, Forman S, et al.. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: phase 2 results from a randomized controlled study. J Am Acad Dermatol. 2021, 85:847-53. 10.1016\/j.jaad.2021.05.050","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372062-efficacy-of-janus-kinase-inhibitors-in-alopecia-in-jordanian-patients-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T09:58:40Z","timestamp":1747562320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372062-efficacy-of-janus-kinase-inhibitors-in-alopecia-in-jordanian-patients-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.84321","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,5,18]]}}}